Medidata Solutions Inc (MDSO)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-PREPACKAGED SOFTWARE

79 FIFTH AVENUE, 8TH FLOOR NEW YORK, NY 10003

Medidata Solutions, Inc. provides hosted clinical development solutions for life science organizations worldwide. Its solutions include software and services that allow customers to achieve clinical results by streamlining the design, planning, and management of key aspects of the clinical development process, including protocol development, contract research organizations (CRO) negotiation, investigator contracting, the capture and management of clinical trial data, and the analysis and reporting of that data on a worldwide basis. The company primarily offers Medidata Rave, a comprehensive platform that integrates electronic data capture with a clinical data management system in a single solution. It also provides Medidata Designer application, a clinical trial protocol authoring tool that enables customers to write trial protocols and automatically configure Medidata Rave. In addition, Medidata Solutions offers Medidata Grants Manager, which enables its customers to benchmark their investigator budgets against industry data, as well as their own grant history; and Medidata CRO Contractor that focuses on benchmarks for CRO outsourcing, budgeting, and negotiation. Further, the company provides professional services, including implementation services to meet customers' data requirements for various indications; workflow design to meet the needs of different study phases and global regulatory requirements; and guidance on best practices for using its application services. Its customers include pharmaceutical, biotechnology, and medical device companies; academic institutions; clinical research organizations; and other entities engaged in clinical trials. The company markets and sells its application services through a direct sales force and through relationships with CROs and other strategic partners.

View SEC Filings from MDSO instead.
Q1 2020 All Institutions Hedge Funds 1
No data found for this quarter.
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MDSO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MDSO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MATEO ALAN EVP GLOBAL SALES

  • Officer
9,873 2020-08-05 0

DOMINGUEZ CARLOS

  • Director
12,857 2020-08-03 1

SHAPIRO LEE CHIEF FINANCIAL OFFICER

  • Officer
5,411,066 2020-07-21 1

SCHLOSS EILEEN

  • Director
5,186 2020-05-20 0

DE VRIES GLEN MICHAEL PRESIDENT

  • Officer
  • Director
0 2019-10-28 1

SHERIF TAREK CHAIRMAN & CEO

  • Officer
  • Director
0 2019-10-28 1

KURTZ NEIL M

  • Director
0 2019-10-28 1

TAYLOR ROBERT

  • Director
0 2019-10-28 1

MCCULLOCH GEORGE

  • Director
0 2019-10-28 1

LARSEN JILL EVP, HUMAN RESOURCES

  • Officer
0 2019-10-28 1

RIVAS MARIA

  • Director
0 2019-10-28 1

OTNER MICHAEL I. EVP-GENERAL COUNSEL

  • Officer
0 2019-10-24 1

SHANNON DANIEL PATRICK EVP, GLOBAL PROFESSIONAL SVCS.

  • Officer
0 2019-10-24 1

BERGMANN ROUVEN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-10-24 1

PRAY MICHAEL EVP, GM GLOBAL SALES

  • Officer
0 2019-10-24 2

CAPONE MICHAEL L

  • Director
25,000 2019-07-31 0

HIRSCHFELD STEVEN ISAAC VICE CHAIRMAN

  • Officer
28,756 2017-02-24 0

WEGER MARY EVP, HUMAN RESOURCES

  • Officer
0 2017-02-24 0

PINTO MICHAEL CHRISTOPHER EVP, GM OF GLOBAL SALES

  • Officer
61,591 2016-02-26 0

COLISTRA DAVID CHIEF ACCOUNTING OFFICER

  • Officer
10,462 2015-07-01 0

DOUGLAS CORY FORMER CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2015-05-16 0

SPIELMAN BRYAN CHARLES

  • EXECUTIVE VICE PRESIDENT
No longer subject to file 2015-02-10 0

WILHITE STEVEN EVP, CHIEF MARKETING OFFICER

  • Officer
3,738 2014-02-10 0

KRASNOW LINEENE NORRIS EVP-PRODUCT & MARKETING

  • Officer
57,366 2013-02-25 0

DALZIEL BRUCE D EVP-FINANCE

  • Officer
74,493 2011-12-19 0

SOBILOFF PETER

  • Director
10,000 2010-11-12 0

INSIGHT VENTURE PARTNERS IV LP

INSIGHT VENTURE ASSOCIATES IV, LLC

INSIGHT VENTURE PARTNERS IV (FUND B), L.P.

INSIGHT HOLDINGS GROUP, LLC

INSIGHT VENTURE PARTNERS IV (CO-INVESTORS), L.P.

INSIGHT VENTURE PARTNERS IV (CAYMAN), L.P.

  • 10% Owner
3,130,542 2010-08-16 0

INSIGHT VENTURE PARTNERS IV LP

INSIGHT VENTURE PARTNERS IV (FUND B), L.P.

INSIGHT VENTURE PARTNERS IV (CO-INVESTORS), L.P.

INSIGHT VENTURE PARTNERS IV (CAYMAN), L.P.

INSIGHT VENTURE ASSOCIATES IV, LLC

  • 10% Owner
0 2009-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments